|
Pt
|
Duration of treatment (months)
|
Findings at the end of treatment
|
Duration of follow-up after treatment discontinuation (months)
|
|---|
|
ESR mm/hr
|
CRP mg/L
|
SAT titers
|
WBC K/μl
|
Clinical
|
MRI residual findings
|
F-18 FDG PET/CT findings
|
F-18 FDG PET/CT SUVmax
|
|---|
|
1
|
12
|
40
|
5.00
|
1/320
|
4.70
|
(−)
|
L5 – S1
|
L2 – L3, L5 – S1
|
3.2 2.6
|
27
|
|
2
|
12
|
10
|
5.00
|
1/680
|
6.50
|
(−)
|
T7 – T8
|
T7 – T8, L4 – L5
|
3.3 2.0
|
13
|
|
3
|
9
|
5
|
3.08
|
1/ 10240
|
4.43
|
(−)
|
L2 – L3
|
L3
|
2.9
|
21
|
|
4
|
12
|
35
|
10.00
|
1/320
|
6.65
|
(−)
|
L4 – L5
|
L5 T6
|
2.6 2.9
|
10
|
|
5
|
6
|
15
|
2.97
|
< 1/160
|
7.24
|
(−)
|
(−)
|
(−)
|
0
|
9
|
|
6
|
11
|
15
|
2.97
|
1/320
|
5.15
|
Back pain on effort
|
L4 – L5
|
L4 – L5
|
2.7
|
8
|
|
7
|
12
|
17
|
3.08
|
< 1/160
|
7.85
|
Pain on weather changes
|
(−)
|
T7
|
2.0
|
17
|
|
8
|
12
|
20
|
4.10
|
< 1/160
|
8.90
|
(−)
|
(−)
|
L3
|
2.0
|
11
|
|
9
|
6
|
14
|
5.00
|
< 1/160
|
7.70
|
(−)
|
(−)
|
L3
|
3.0
|
21
|
|
10
|
12
|
23
|
5.00
|
< 1/160
|
4.80
|
Back pain on effort
|
L4 – L5
|
L1 – L2, L4 – L5
|
2.9 4.4
|
12
|
- NOTES. Pt: patient number, ESR: erythrocyte sedimentation rate (normal value, 40 mm/hour), CRP: C-reactive protein (normal values < 5 mg/L), WBC: white blood count, SAT: slide agglutination test (normal values < 1/160), MRI: magnetic resonance imaging, F-18 FDG PET/CT: fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography combined with computed tomography scan, SUVmax: maximum standard uptake value.
